{"nct_id":"NCT01222078","title":"Investigating Re-Dosing With Otelixizumab in Adults With Newly-Diagnosed Type 1 Diabetes Mellitus","status":"TERMINATED","status_verified_date":"2020-10","start_date":"2010-11-22","start_date_type":"ACTUAL","primary_completion_date":"2011-05-19","primary_completion_date_type":"ACTUAL","completion_date":"2011-05-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}